Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters










Publication year range
1.
Mucosal Immunol ; 10(5): 1202-1210, 2017 09.
Article in English | MEDLINE | ID: mdl-28051088

ABSTRACT

Inflammatory damage of mucosal surface of the eye is a hallmark of dry eye disease (DED) and, in severe cases, can lead to significant discomfort, visual impairment, and blindness. DED is a multifactorial autoimmune disorder with a largely unknown pathogenesis. Using a cross-sectional patient study and a well-characterized murine model of DED, herein we investigated the immunoregulatory function of interleukin-22 (IL-22) in the pathogenesis of DED. We found that IL-22 levels were elevated in lacrimal fluids of DED patients and inversely correlated with severity of disease. Acinar cells of the lacrimal glands (LGs), not inflammatory immune cells, are the primary source of IL-22, which suppresses inflammation in ocular surface epithelial cells upon desiccating stress. Moreover, loss of function analyses using IL-22 knockout mice demonstrated that IL-22 is essential for suppression of ocular surface infiltration of Th17 cells and inhibition of DED induction. Our novel findings elucidate immunoregulatory function of LG-derived IL-22 in inhibiting IL-17-mediated ocular surface epitheliopathy in DED thus making IL-22 a new relevant therapeutic target.


Subject(s)
Acinar Cells/immunology , Dry Eye Syndromes/immunology , Eye/pathology , Interleukins/metabolism , Lacrimal Apparatus/physiology , Mucous Membrane/immunology , Th17 Cells/immunology , Adult , Aged , Animals , Cross-Sectional Studies , Female , Humans , Interleukin-17/metabolism , Interleukins/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , Transplantation Chimera , Interleukin-22
2.
Biochim Biophys Acta ; 1854(5): 391-401, 2015 May.
Article in English | MEDLINE | ID: mdl-25592991

ABSTRACT

Methods for isolating elastin from fat, collagen, and muscle, commonly used in the design of artificial elastin based biomaterials, rely on exposing tissue to harsh pH levels and temperatures that usually denature many proteins. At present, a quantitative measurement of the modifications to elastin following isolation from other extracellular matrix constituents has not been reported. Using magic angle spinning (13)C NMR spectroscopy and relaxation methodologies, we have measured the modification in structure and dynamics following three known purification protocols. Our experimental data reveal that the (13)C spectra of the hydrated samples appear remarkably similar across the various purification methods. Subtle differences in the half maximum widths were observed in the backbone carbonyl suggesting possible structural heterogeneity across the different methods of purification. Additionally, small differences in the relative signal intensities were observed between purified samples. Lyophilizing the samples results in a reduction of backbone motion and reveals additional differences across the purification methods studied. These differences were most notable in the alanine motifs indicating possible changes in cross-linking or structural rigidity. The measured correlation times of glycine and proline moieties are observed to also vary considerably across the different purification methods, which may be related to peptide bond cleavage. Lastly, the relative concentration of desmosine cross-links in the samples quantified by MALDI mass spectrometry is reported.


Subject(s)
Elastin/chemistry , Elastin/isolation & purification , Amino Acid Sequence , Animals , Carbon-13 Magnetic Resonance Spectroscopy , Cattle , Kinetics , Protein Structure, Tertiary , Sequence Analysis, Protein , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Temperature
3.
J Frailty Aging ; 4(1): 34-40, 2015.
Article in English | MEDLINE | ID: mdl-27031913

ABSTRACT

BACKGROUND: Bioimpedance analysis (BIA) is known to be a useful method for assessing sarcopenia because cost-effective and not involving radiation exposure. However, the cut-off values for sarcopenia using BIA have not yet been determined in the Korean population. OBJECTIVES: To establish the cut-off values for sarcopenia in the Korean elderly population with the use of BIA. METHODS: Body composition assessed by BIA was obtained in 7,641 participants aged 20-34 years and 3,902 participants aged ≥65 years from data routinely collected during health examinations at Seoul National University Gangnam Center. Appendicular skeletal muscle mass was adjusted for height and weight. Gender-specific cut-points for class I and class II sarcopenia were defined as 1 and 2 standard deviations below the mean in the reference group aged 20-34 years, respectively. In addition, the gender-specific, lowest 20th percentile cut-offs for muscle mass in participants aged ≥65 years were determined. RESULTS: The cut-offs for class I and class II sarcopenia in men for height-adjusted appendicular skeletal mass were 6.74 kg/m2 and 5.96 kg/m2 and for weight-adjusted appendicular skeletal mass were 29.4% and 27.4%, respectively; those in women for height-adjusted appendicular skeletal mass were 4.93 kg/m2 and 4.35 kg/m2, and for weight-adjusted appendicular skeletal mass were 25.6% and 23.9%, respectively. The lowest 20th percentile cut-offs for height-adjusted and weight-adjusted appendicular skeletal mass were 6.69 kg/m2 and 28.9% in men, and 5.76 kg/m2 and 24.5% in women, respectively. Based on the derived cut-offs, prevalence of class II sarcopenia in participants ≥65 years of age for height-adjusted and weight-adjusted appendicular skeletal mass was 3.7% and 3.5% in men, and 0.2% and 11.2% in women, respectively. Among the above-mentioned definitions, sarcopenia by height-adjusted appendicular skeletal mass was significantly associated with 2-year mortality in older participants. CONCLUSIONS: Muscle mass deficit in the Korean population can be assessed based on the cut-offs determined in this study using BIA.

4.
Cell Death Dis ; 5: e1309, 2014 Jun 26.
Article in English | MEDLINE | ID: mdl-24967971

ABSTRACT

The pathogenesis of immune-mediated lacrimal gland (LG) dysfunction in Sjögren's syndrome has been thoroughly studied. However, the majority of dry eye (DE) is not related to Sjögren type, and its pathophysiology remains unclear. The purpose of this study was to determine and investigate the protective mechanisms against DE stress in mice. DE induced prominent blood vessel loss without apoptosis or necrosis in the LG. Autophagic vacuoles, distressed mitochondria, and stressed endoplasmic reticulum were observed via electron microscopy. Immunoblotting confirmed the increase in autophagic markers. Glycolytic activities were enhanced with increasing levels of succinate and malate that, in turn, activated hypoxia-inducible factor (HIF)-1α. Interestingly, the areas of stable HIF-1α expression overlapped with COX-2 and MMP-9 upregulation in LGs of DE-induced mice. We generated HIF-1α conditional knockout (CKO) mice in which HIF-1α expression was lost in the LG. Surprisingly, normal LG polarities and morphologies were completely lost with DE induction, and tremendous acinar cell apoptosis was observed. Similar to Sjögren's syndrome, CD3(+) and CD11b(+) cells infiltrated HIF-1α CKO LGs. Our results show that DE induced the expression of HIF-1α that activated autophagy signals to prevent further acinar cell damage and to maintain normal LG function.


Subject(s)
Autophagy , Hypoxia-Inducible Factor 1, alpha Subunit/biosynthesis , Lacrimal Apparatus/metabolism , Sjogren's Syndrome/metabolism , Animals , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Female , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Lacrimal Apparatus/pathology , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Knockout , Sjogren's Syndrome/genetics , Sjogren's Syndrome/pathology , Sjogren's Syndrome/prevention & control
5.
Clin Exp Rheumatol ; 27(4): 620-5, 2009.
Article in English | MEDLINE | ID: mdl-19772794

ABSTRACT

OBJECTIVE: Ankylosing spondylitis (AS) is an inflammatory arthritis involving the axial skeleton. Decreased bone mineral density has also been reported in AS patients. This study sought to determine whether osteoclastogenesis and osteoclast activity are increased in AS. METHODS: Twenty patients with AS were evaluated using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and other clinical parameters. Mononuclear cells were separated out from peripheral blood samples taken from AS patients and normal healthy controls and cultured with monocyte colony stimulating factor and receptor activator of the nuclear factor kappa B ligand (RANKL). Multi-nucleated, tartrate-resistant acid phosphatase stain-positive osteoclasts were counted after 9 days, and the areas of calcium absorption on calcium-coated plates were determined. RESULTS: Osteoclastogenesis was significantly greater in AS patients than in normal controls (number of osteoclasts/1106 mononuclear cells, median, 518.0 vs. 362.5, p=0.036). No differences were observed between AS patients and controls in terms of calcium absorption areas or the serum concentrations of tumor necrosis factor and RANKL. Osteoclastogenesis was greater in AS patients with sacroiliac joint ankylosis than in those without. Osteoclastogenesis and the calcium absorption area were not found to be correlated with BASDAI nor with other clinical parameters including age, erythrocyte sedimentation rate, and C-reactive protein levels. CONCLUSION: Osteoclastogenesis is elevated in AS patients, especially in those with sacroiliac joint ankylosis. Increased osteoclastogenesis may be related to osteopenia in AS patients.


Subject(s)
Bone Resorption/physiopathology , Osteoclasts/physiology , Receptor Activator of Nuclear Factor-kappa B/physiology , Spondylitis, Ankylosing/physiopathology , Acid Phosphatase/metabolism , Adult , Bone Resorption/pathology , Calcium/metabolism , Cell Separation , Cells, Cultured , Drug Combinations , Female , Health Status , Humans , Isoenzymes/metabolism , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Macrophage Colony-Stimulating Factor/pharmacology , Male , Osteoclasts/drug effects , Osteoclasts/enzymology , RANK Ligand/pharmacology , Receptor Activator of Nuclear Factor-kappa B/pharmacology , Severity of Illness Index , Spondylitis, Ankylosing/metabolism , Spondylitis, Ankylosing/pathology , Tartrate-Resistant Acid Phosphatase , Tumor Necrosis Factor-alpha/blood , Young Adult
6.
Cell Death Differ ; 16(10): 1332-43, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19543237

ABSTRACT

Interleukin-17 (IL-17) is a cytokine secreted primarily by T(H)-17 cells. Although IL-17 is primarily associated with the induction of tissue inflammation, the other biological roles of IL-17, including non-immune functions, have yet to be thoroughly explored. Here, we report that T-cell-produced IL-17 can induce proliferation of human bone marrow-derived mesenchymal stem cells (hMSCs) in a manner dependent on the generation of reactive oxygen species (ROS). Rac1 GTPase and NADPH oxidase 1 (Nox1) are activated by IL-17 to produce ROS, which in turn stimulates hMSC proliferation. The activation of the MEK-ERK pathway is also crucial for IL-17-dependent hMSC proliferation. TRAF6 and Act1 are required to activate Nox 1 and to phosphorylate MEK on IL-17 stimulation. Interestingly, IL-17 not only accelerates the proliferation of hMSCs, but also induces their migration, motility, and osteoblastic differentiation. Furthermore, IL-17 induces the expression of M-CSF and receptor activator of NF-kappaB ligand (RANKL) on hMSCs, thereby supporting osteoclastogenesis both in vivo and in vitro. On the basis of these results, we suggest that IL-17 can function as a signal to induce extensive bone turnover by regulating hMSC recruitment, proliferation, motility, and differentiation.


Subject(s)
Bone Remodeling , Cell Differentiation , Cell Proliferation , Interleukin-17/metabolism , Mesenchymal Stem Cells/cytology , Azacitidine/pharmacology , Cell Movement , Connexin 43/genetics , Connexin 43/metabolism , Core Binding Factor Alpha 1 Subunit/metabolism , Cyclooxygenase 2/metabolism , Humans , Macrophage Colony-Stimulating Factor/metabolism , Mesenchymal Stem Cells/metabolism , NADPH Oxidase 1 , NADPH Oxidases/genetics , NADPH Oxidases/metabolism , Peptide Fragments/genetics , Peptide Fragments/metabolism , RANK Ligand/metabolism , RNA, Small Interfering/metabolism , Reactive Oxygen Species/metabolism , Signal Transduction , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , TNF Receptor-Associated Factor 6/genetics , TNF Receptor-Associated Factor 6/metabolism
7.
Inflamm Res ; 57(4): 189-98, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18363035

ABSTRACT

OBJECTIVE: Paeony root has long been used for its anti-inflammatory effects. In this study, the effects of albiflorin, paeoniflorin, and paeonol, compounds from paeony root, on gene expression profiles were examined in macrophages challenged with the inflammation inducer lipopolysaccharide (LPS). METHODS: The RAW264.7 macrophages were treated with LPS in the presence or absence of albiflorin, paeoniflorin, or paeonol. Global mRNA expression levels were detected by using an oligonucleotide microarray platform covering the mouse whole genome. RESULTS: Treatment with LPS caused expression level changes in 1,270 genes by 2 folds or more. Paeonol attenuated the induction level of 355 LPS-responsive genes. Classification of the genes targeted by paeonol according to the Panther group analysis revealed 20 biological processes, 24 molecular functions, and 22 signaling pathways. The Panther signaling pathways highly affected by paeonol included the 'inflammation mediated by chemokine and cytokine signaling', 'interleukin signaling', and 'Toll receptor signaling'. CONCLUSION: Our results demonstrate that paeonol has extensive inhibitory effects on the regulation of inflammation associated gene expression by LPS in macrophages. In addition, the predominant effect of paeonol among the tested compounds suggests that paeonol may be a major ingredient for the anti-inflammatory effect of paeony root.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Gene Expression Profiling , Inflammation/genetics , Inflammation/prevention & control , Macrophages/metabolism , Oligonucleotide Array Sequence Analysis , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Benzoates/pharmacology , Bridged-Ring Compounds/pharmacology , Cells, Cultured , Chemokines/genetics , Chemokines/metabolism , Gene Expression Regulation/drug effects , Glucosides/pharmacology , Inflammation/chemically induced , Interleukins/genetics , Interleukins/metabolism , Lipopolysaccharides/adverse effects , Macrophages/cytology , Macrophages/drug effects , Mice , Monoterpenes , Toll-Like Receptors/genetics , Toll-Like Receptors/metabolism
8.
Transplant Proc ; 38(7): 2214-5, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16980046

ABSTRACT

OBJECTIVES: The damage induced by oxygen free radicals (OFRs) is caused by an imbalance of the production of versus the antioxidant defenses against OFRs. METHODS: To understand hepatic damage induced by oxygen free radicals after hepatectomy in rats, total antioxidant status and total production of oxygen free radicals were serially measured in regeneration liver. At 1, 2, 3, 7, and 10 days after hepatectomy of Sprague-Dawley rats, blood was obtained into a capillary tube from a tail vein. Total antioxidant status and total production of oxygen free radicals were measured using the Randox kit, a colorimetric method, and the Free Radical Analytical System. We also measured the amount of malonyldialdehyde, which provides an indirect index of oxidative injury. RESULTS: The level of malonyldialdehyde after hepatectomy was higher compared with that before hepatectomy. The level of total oxygen free radicals after hepatectomy was higher compared with that before hepatectomy. Total antioxidant status after hepatectomy was lower compared with that before hepatectomy. CONCLUSIONS: The results suggested that the damage by OFRs to the regenerating liver was caused by increased production of OFRs and decreased antioxidant defense against OFRs.


Subject(s)
Antioxidants/metabolism , Liver Regeneration/physiology , Reactive Oxygen Species/metabolism , Animals , Free Radicals , Male , Malondialdehyde/metabolism , Oxygen Consumption , Rats , Rats, Sprague-Dawley
9.
Transplant Proc ; 38(7): 2240-1, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16980053

ABSTRACT

OBJECTIVES: Cyclosporine (CsA) and tacrolimus (Tac) are two primary immunosuppressive agents used for the prevention of graft rejection. However, their use is associated with significant side effects, most notably nephrotoxicity. The mechanisms of this toxicity are not fully understood, but they seem to be associated with increases in the production of oxygen free radicals (OFRs). This present work examined the effect of CsA and Tac on the production of OFRs in cultured rat renal mesangial cells (RMCs). METHODS: Varying concentrations of CsA and Tac (0 to 40 micromol/L) were added to RMCs and incubated for 60 minutes at 37 degrees C. The production of OFRs was evaluated by measuring the fluorescent product from the oxidation of an oxidant-sensitive 2', 7'-dichlorofluorescin. RESULTS: At 60 minutes, the relative fluorescence units (RFU) for OFRs production in RMCs exposure to CsA were increased by 2.5%, 11.5%, 22.5%, 57.2%, and 174% at 2.5, 5, 10, 20, and 40 micromol/L, respectively. Tac increased the RFU by 15.9%, 13.6%, 14.8%, 13.2%, 21.4%, 13.2%, and 28.1% at 0.1, 1, 2.5, 5, 10, 20, and 40 micromol/L, respectively. In RMCs, the RFU produced by CsA was higher than that by Tac. CONCLUSIONS: The results of this experiment suggest that CsA and Tac induced renal injury by OFRs.


Subject(s)
Cyclosporine/pharmacology , Glomerular Mesangium/physiology , Oxidative Stress/physiology , Tacrolimus/pharmacology , Animals , Cells, Cultured , Glomerular Mesangium/drug effects , Oxidative Stress/drug effects , Rats
10.
Transplant Proc ; 38(7): 2237-9, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16980052

ABSTRACT

INTRODUCTION: Posttransplant bone disease is one of the complications of cyclosporine (CsA), which is widely used as an immunosuppressive agent in the field of kidney transplantation. Cyclosporine treatment causes osteopenia as a result of altered bone turnover, but the pathogenic mechanisms of this process remain unclear. This study examined the ability of CsA to induce apoptosis in a rat osteoblast cell line. RESULTS: We induced apoptosis in rat osteoblastic ROS 17/2.8 cells by exposure to CsA. MTT assay showed that CsA exhibited significant cytotoxic effects on ROS 17/2.8 cells in a dose-dependent manner. Western blot analysis showed enhanced processing of caspase-8, Bax, and p53 after CsA treatment. Expression of cleaved poly (ADP-ribose) polymerase (PARP) was elevated by CsA treatment. Pro-caspase-3 and Bcl-2 proteins were decreased by CsA. CONCLUSIONS: These results suggested that CsA induced apoptosis of osteoblasts.


Subject(s)
Apoptosis/drug effects , Cyclosporine/pharmacology , Animals , Bone Neoplasms , Cell Line, Tumor , Cell Survival/drug effects , Immunosuppressive Agents/pharmacology , Osteoblasts/drug effects , Osteoblasts/immunology , Osteoblasts/pathology , Osteosarcoma , Rats
11.
Transplant Proc ; 38(7): 2242-3, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16980054

ABSTRACT

OBJECTIVES: Cyclosporine (CsA) causes side effects that occur mainly in the kidney but also in the liver. Several reports have strongly suggested that the production of oxygen free radicals (OFRs) is a common mechanism of CsA toxicity. However, tacrolimus is believed to suppress the production of OFRs. METHODS: We obtained the mitochondrial fraction with 96% purity from rat liver using a sucrose density gradient solution. Zero to 100 micromol/L tacrolimus was incubated with the mitochondrial fraction for 6 hours at 37 degrees C. OFRs were evaluated by measuring the fluorescent product from the oxidation of an oxidant-sensitive 2,7-dichlorefluorescein using a VICTOR3 multilabel counter. RESULTS: The fluorescence units for OFR production were increased as the time of exposure to tacrolimus passed from 1 to 6 hours. The fluorescence units in 0.1 micromol/L tacrolimus were 6.0 x 10(5) at 1 hour, 7.8 x 10(5) at 2 hours, 9.0 x 10(5) at 3 hours, 10.0 x 10(5) at 4 hours, 11.1 x 10(5) at 5 hours, and 11.4 x 10(5) at 6 hours. However, the fluorescence units were similar although the tacrolimus concentration increases from 0.1 to 100 micromol/L. CONCLUSIONS: The results in this experiment suggested that tacrolimus induced the production of OFRs depending on the exposure time.


Subject(s)
Mitochondria, Liver/physiology , Reactive Oxygen Species/metabolism , Tacrolimus/pharmacology , Animals , Free Radicals , Male , Mitochondria, Liver/drug effects , Rats , Rats, Sprague-Dawley , Spectrometry, Fluorescence
12.
Transplant Proc ; 38(7): 2244-6, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16980055

ABSTRACT

INTRODUCTION: The immunosuppressive agent cyclosporine (CsA) is widely used to treat allograft rejection and various autoimmune disorders. A major limiting factor in the use of CsA is chronic nephrotoxicity. The pathogenesis of CsA-induced nephrotoxicity is not fully understood. Several recent studies have suggested that CsA treatment directly induces apoptosis in several cell types. The present study was undertaken to investigate the effects of CsA on apoptosis of cultured rat mesangial cells (RMCs). METHODS: RMCs were treated with CsA at concentrations of 0.1 to 40 mumol/L. Cell viability was determined by MTT assay. Apoptotic protein expression was determined by Western blot analysis. RESULTS: Cell viability was decreased with increasing concentrations of CsA in dose-dependent manner. CsA produced dose-dependent induction of p53, caspase-6, and Bax protein expression. CsA treatment caused proteolytic cleavage of caspase-3 and induced the degradation of 116-kDa PARP into 89-kDa fragment. RMCs with CsA reduced Bcl-2 and cIAP expression. CONCLUSIONS: In this study, CsA induced apoptosis by up-regulating proapoptotic factors, caspase-3 and -6, p53, Bax, cleaving PARP, and down-regulating antiapoptotic factor, Bcl-2, and cIAP. These results suggested that the increased cell apoptosis exerted by CsA may be one of the mechanisms promoting CsA-induced nephrotoxicity.


Subject(s)
Apoptosis/drug effects , Cyclosporine/pharmacology , Glomerular Mesangium/cytology , Animals , Apoptosis/physiology , Cell Survival/drug effects , Cells, Cultured , Glomerular Mesangium/drug effects , Glomerular Mesangium/physiology , Rats
13.
J Periodontal Res ; 41(4): 288-96, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16827722

ABSTRACT

BACKGROUND AND OBJECTIVE: Lipopolysaccharide is thought to be a major virulence factor of pathogens associated with periodontal diseases and is believed to stimulate bone resorption in vivo. Although Prevotella nigrescens has been implicated in periodontitis, its role in osteoclastogenesis has not been reported. In this study, we investigated the effects of lipopolysaccharide from P. nigrescens on the formation of osteoclasts and the production of cytokines related to osteoclast differentiation. MATERIAL AND METHODS: Mouse bone marrow mononuclear cells were cultured in the presence of macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappaB ligand (RANKL), with or without lipopolysaccharide. Bone marrow mononuclear cells were also cocultured with calvarial osteoblastic cells in the presence or absence of lipopolysaccharide. Osteoclast formation was determined by tartrate-resistant acid phosphatase cytochemistry. The production of osteoprotegerin (OPG), M-CSF, tumor necrosis factor alpha (TNF-alpha), transforming growth factor-beta (TGF-beta) and prostaglandin E2 (PGE2) was determined by enzyme-linked immunosorbent assay (ELISA). RESULTS: P. nigrescens lipopolysaccharide inhibited osteoclast differentiation from bone marrow mononuclear cells cultured in the presence of M-CSF and RANKL. However, in the coculture system, P. nigrescens lipopolysaccharide stimulated osteoclastogenesis. Notably, P. nigrescens lipopolysaccharide decreased OPG production but increased TGF-beta secretion. In addition, treatment with P. nigrescens lipopolysaccharide increased PGE2 production during the late stage of the culture period. There was no difference in M-CSF and TNF-alpha production. CONCLUSION: These results demonstrate that P. nigrescens lipopolysaccharide stimulates osteoclastogenesis in the coculture system by decreasing the production of OPG and increasing the production of TGF-beta and PGE2. Through the mechanisms involving these factors, P. nigrescens lipopolysaccharide may cause alveolar bone resorption in periodontal diseases.


Subject(s)
Alveolar Bone Loss/microbiology , Lipopolysaccharides/pharmacology , Osteoclasts/drug effects , Prevotella nigrescens/pathogenicity , Animals , Bone Marrow Cells/drug effects , Carrier Proteins/metabolism , Cell Differentiation/drug effects , Cells, Cultured , Coculture Techniques , Dinoprostone/biosynthesis , Female , Glycoproteins/biosynthesis , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred ICR , Osteoblasts/drug effects , Osteoclasts/cytology , Osteoprotegerin , RANK Ligand , Receptor Activator of Nuclear Factor-kappa B , Receptors, Cytoplasmic and Nuclear/biosynthesis , Receptors, Tumor Necrosis Factor/biosynthesis , Transforming Growth Factor beta/biosynthesis
14.
Cell Death Differ ; 13(11): 1879-91, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16498455

ABSTRACT

Osteoclast (Oc) differentiation is fundamentally controlled by receptor activator of nuclear factor kappaB ligand (RANKL). RANKL signalling targets include mitogen-activated protein kinases (MAPKs), nuclear factor kappaB (NF-kappaB), and nuclear factor of activated T cells (NFAT)c1. In this study, we found that p38 MAPK upstream components transforming growth factor-beta-activated kinase 1 (TAK1), MKK3, and MKK6 increased by RANKL in an early stage of osteoclastogenesis from primary bone marrow cells, which led to enhanced p38 activation. Retroviral transduction of dominant-negative (DN) forms of TAK1 and MKK6, but not that of MKK3, reduced Oc differentiation. Transduction of TAK1-DN and MKK6-DN and treatment with the p38 inhibitor SB203580 attenuated NFATc1 induction by RANKL. TAK1-DN, MKK6-DN, and SB203580, but not MKK3-DN, also suppressed RANKL stimulation of NF-kappaB transcription activity in a manner dependent on p65 phosphorylation on Ser-536. These results indicate that TAK1 and MKK6 constitute the p38 signalling pathway to participate to Oc differentiation by RANKL through p65 phosphorylation and NFATc1 induction, and that MKK6 and MKK3 have differential roles in osteoclastogenesis from bone marrow precursors.


Subject(s)
Cell Differentiation/physiology , MAP Kinase Kinase 6/metabolism , MAP Kinase Kinase Kinases/metabolism , NF-kappa B/metabolism , Osteoclasts/cytology , RANK Ligand/pharmacology , Transcriptional Activation/drug effects , Animals , Cells, Cultured , Enzyme Activation/drug effects , MAP Kinase Kinase 3/antagonists & inhibitors , MAP Kinase Kinase 6/antagonists & inhibitors , Mice , NFATC Transcription Factors/metabolism , Osteogenesis/drug effects , Phosphorylation/drug effects , Phosphoserine/metabolism , Signal Transduction/drug effects , Stem Cells/drug effects , Transcription, Genetic/drug effects , Up-Regulation/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism
15.
Transplant Proc ; 37(5): 2385-6, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15964422

ABSTRACT

INTRODUCTION: Hemolysis is one of the side effects of cyclosporine (CsA) therapy, in part due to, increased production of free radical species by CsA. Epigallocatechin gallate (EGCG), which acts as a highly efficient free radical scavenger, may have a protective effect on CsA-induced hemolysis. In this study, we measured the degree of hemolysis of as well as the amounts of hydrogen peroxide level and malondialdehyde produced by normal human erythrocytes (RBCs) incubated with CsA and with EGCG. METHODS: Human RBCs were incubated as follows. In group 1, 4.2 x 10(6)/mL RBCs were incubated with Cremophore EL. In group 2, the RBCs were incubated with only 167 microg/mL EGCG. In group 3, the RBCs were incubated with 1.67 mg/mL CsA. In group 4, the RBCs were incubated with CsA plus EGCG. RESULTS: The degree of hemolysis in group 2 (53.8 +/- 3.8) was significantly higher than that in group 1 (7.0 +/- 1.0). The degree of hemolysis in group 3 (86.2 +/- 2.2) was significantly higher than that in group 1 and group 2. The degree of hemolysis in group 4 (74.9 +/- 2.9) was significantly higher than in group 1 and in group 2, but lower than that in group 3. The hydrogen peroxide and malondialdehyde levels paralleled the degree of hemolysis. CONCLUSIONS: These results suggest that CsA can induce free radical-mediated hemolysis, which can be partially prevented with EGCG.


Subject(s)
Catechin/analogs & derivatives , Cyclosporine/toxicity , Free Radical Scavengers/pharmacology , Hemolysis/physiology , Catechin/pharmacology , Erythrocytes/drug effects , Erythrocytes/physiology , Hemolysis/drug effects , Humans , In Vitro Techniques
16.
Transplant Proc ; 36(7): 1952-4, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15518709

ABSTRACT

INTRODUCTION: The kidney suffers ischemia-reperfusion (I/R) injury during transplantation. The purpose of the present study was to investigate the therapeutic effect of artificials cells on renal I/R injury through biochemical assays and histological examination. METHODS: We prepared artificial cells using cross-linked hemoglobin (Hb), superoxide dismutase (SOD), and catalase. Normal male Sprague-Dawley rats were divided into 6 groups: the sham-operated control group, the group treated with polyHb,and the group treated with polyHb-SOD-catalase (PSC) (per groups were subjected to ischemia for 1 hour or 2 hours). After reperfusion for 4 hours, kidney and blood samples were obtained. RESULTS: The levels of SOD and catalase in the PSC group were 15 and 50 times higher than those of the control group, respectively. In the polyHb group, the levels of blood urea nitrogen (BUN), serum creatinine, renal hydrogen peroxide, and renal malondialdehyde were increased. However, their levels were significantly decreased by PSC administration. Renal SOD activity did not show any significant changes in the polyHb group, but renal catalase activity was decreased by polyHb treatment in comparison with the control group. The activities of renal SOD and catalase were increased using PSC treatment. In the histological findings, the PSC group showed no evidence of acute tubular necrosis in proximal convoluted tubules; their microvilli and cytoplasmic microorganelles were relatively well preserved. CONCLUSIONS: These results show that PSC effectively reduces renal damage via diminished oxygen free radical-mediated injury after I/R.


Subject(s)
Blood Substitutes/pharmacology , Catalase/pharmacology , Hemoglobins/pharmacology , Kidney , Reperfusion Injury/prevention & control , Superoxide Dismutase/pharmacology , Animals , Blood Urea Nitrogen , Free Radicals/metabolism , Kidney Function Tests , Male , Rats , Rats, Sprague-Dawley , Renal Circulation/drug effects
17.
Transplant Proc ; 36(7): 1959-61, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15518711

ABSTRACT

BACKGROUND: The liver suffers from ischemia/reperfusion injury during transplantation. Reactive oxygen species generated by xanthine oxidase during reperfusion of the ischemic liver may be partially responsible for the hepatic injury. Oxygen free radicals are removed by antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase. Using glutaraldehyde and lysine we constructed crosslinked hemoglobin, containing SOD and catalase, and assessed its ability to protect against ischemia/reperfusion injury during transplantation. METHODS: In contrast to the sham-operated control groups, blood was exchanged using crosslinked hemoglobin (polyHb) a PolyHb-SOD-catalase (PSC) group. After ischemia/reperfusion injury, several parameters of hepatic damage and oxygen free radicals were measured as well as microscopic examination. RESULTS: Alanine aminotransferase, aspartate aminotransferase, superoxide production, hydrogen peroxide, and malondialdehyde levels were higher among the PolyHb group than sham-operated controls. The PolyHb group revealed a few apoptotic bodies, some acute inflammatory infiltrates in the sinusoids, nuclear fragmentations, cell shrinkage, and chromatin clumping with formation of apoptotic bodies in the apoptotic cells under microscopic examination. Alanine aminotransferase, aspartate aminotransferase, superoxide production, and hydrogen peroxide levels were lower in the PSC than the PolyHb group. Hepatic structures were well preserved in the PSC group. CONCLUSIONS: Reactive oxygen species contribute to hepatic dysfunction with morphologic changes. PSC is effective to reduce hepatic damage by lowering oxygen free radical-mediated injury after ischemia/reperfusion in the liver.


Subject(s)
Catalase/pharmacology , Hemoglobins/pharmacology , Liver Function Tests , Liver/physiology , Reperfusion Injury/physiopathology , Superoxide Dismutase/pharmacology , Animals , Blood Substitutes/pharmacology , Free Radicals/metabolism , Ischemia , Male , Rats , Rats, Sprague-Dawley
18.
Transplant Proc ; 36(7): 2133-4, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15518774

ABSTRACT

INTRODUCTION: Nephrotoxicity is a clinically important side effect of cyclosporine (CsA). CsA-induced nephrotoxicity results from increased production of free radical species in the kidney. Epigallocatechin gallate (EGCG) acts as an antioxidant, thus, EGCG may have a protective effect on the alteration of renal function resultant from oxygen free radicals. The purpose of the present study was to investigate the protective effect of EGCG in a rodent model. METHODS: Experiments were performed on 3 groups. The normal control group (group 1) received normal saline solution. The CsA-treated group (group 2; 15 mg/kg body weight/d for 14 days) received subcutaneous injections. The EGCG-treated group (group 3) in addition received 25 mg of EGCG/kg body weight by intraperitoneal injection. RESULTS: There were significant increases in levels of blood urea nitrogen (BUN)(42.8 +/- 8.2 mg/dL; P < .001), serum creatinine (1.18 +/- 0.60 mg/dL; P < .05), and serum malondialdehyde (3.09 +/- 0.20 nmol/mL; P < .001), and a significant decrease in CCr(0.07 +/- 0.02 mL/min; P < .001) in group 2 compared with group 1. Levels of BUN (30.2 +/- 0.7 mg/dL; P < .01)and CCr (0.12 +/- 0.08 mL/min) were lower in group 3 than in group 2. Serum creatinine (0.71 +/- 0.04 mg/dL) and serum malondialdehyde level (2.13 +/- 0.15; P < .001 nmol/mL) were lower in group 3 than in group 2. There was no significant difference in CsA levels between group 2 (6.86 +/- 1.48 mug/mL) and group 3 (6.69 +/- 0.62 mug/mL). CONCLUSIONS: EGCG treatment significantly protected renal function and free radical-mediated injury in the kidney from CsA-induced changes.


Subject(s)
Antioxidants/therapeutic use , Catechin/analogs & derivatives , Catechin/therapeutic use , Cyclosporine/toxicity , Kidney Transplantation/pathology , Blood Urea Nitrogen , Creatinine/blood , Humans , Kidney/drug effects , Kidney/immunology , Kidney/pathology , Kidney Function Tests , Kidney Transplantation/immunology
19.
Transplant Proc ; 36(7): 2165-6, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15518787

ABSTRACT

INTRODUCTION: Cyclosporine (CsA) may contribute to oxygen free radical metabolism in neutrophils, thus resulting in the damage to these cells. This damage may be mitigated by antioxidants such as melatonin. In this study, we measured the malondialdehyde level, which was used as a marker of free radical-induced tissue damage from neutrophils in rats treated with CsA and melatonin. METHODS: The experiments included the following: (1) normal controls (group 1) that received Cremophor EL and 0.5 mL of 5% ethanol-saline solution; (2) CsA alone-treated (group 2) rats that received 15 mg/kg of body weight per day for 14 days by subcutaneous injection; and (3) melatonin-treated (group 3) rats received CsA as for group 2 plus melatonin (715 mug). RESULTS: Malondialdehyde level was significantly higher among group 2 (13.34 +/- 7.54 nmol/10(7) neutrophils) than group 1 animals (7.33 +/- 2.63 nmol/10(7) neutrophils; P < .05). The level was significantly lower in group 3 (5.58 +/- 1.59 nmol/10(7) neutrophils) than group 2 (P < .01). CsA levels were not significantly different between group 2 (6.25 +/- 1.60 mug/mL) and group 3 (6.09 +/- 2.01 mug/mL). CONCLUSIONS: In this experiment, the malondialdehyde level in neutrophils was increased after CsA treatment, suggesting that damage resulted from oxygen free radicals by CsA. This damage was reduced by melatonin. Thus, CsA-induced neutrophils oxidative damage may be protected by melatonin in transplant recipients.


Subject(s)
Cyclosporine/pharmacology , Glycerol/analogs & derivatives , Malondialdehyde/blood , Melatonin/pharmacology , Neutrophils/physiology , Animals , Glycerol/pharmacology , Male , Neutrophils/drug effects , Neutrophils/immunology , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...